Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2013

May 15, 2013

30643_dirs_2013-05-15_46ed11a4-dc9c-4733-a742-99372ea43aa6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2013-05-13

Reporting Person: Kogod Dennis (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-13 Common Stock M 22750 $63.40 Acquired 61937 Direct
2013-05-13 Common Stock F 10995 $131.19 Disposed 50942 Direct
2013-05-13 Common Stock S 11755 $129.6049 Disposed 39187 Direct
2013-05-15 Common Stock S 9375 $129.3017 Disposed 29812 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-13 Stock Appreciation Right $63.40 M 22750 Disposed 2015-03-31 Common Stock (22750) Direct

Footnotes

F1: The range of prices for the sale of these shares was $128.87 - $130.37. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F2: The range of prices for the sale of these shares was $129.19 - $129.40. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F3: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.